Baxter International Inc.

BAX Healthcare Medical Instruments & Supplies

Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024. In the quarter to June 2026, revenue grew 5.34%, EPS grew 33.3%, free cash flow grew 119.5% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

25.33 0.43 −1.67%
Market cap
$13.3B
P/E
0.0×
Fwd P/E
44.7×
Dividend yield
0.16%
F-score
4/9
Altman Z
2.12
Beneish M
−2.67
Dividend safety
0/100

Baxter International Inc. (BAX) EV/FCF

Alert me on EV/FCF

As of 16 October 2026, Baxter International Inc. (BAX) trades at a EV/FCF of 25.0×. Over the past ten years it has ranged from 10.8× (September 2015) to 123× (March 2025); the current reading is higher than 23% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 52.1× 13.90%
FY2024 45.8× 95.29%
FY2023 23.4× (51.89%)
FY2022 48.7× 29.08%
FY2021 37.8× 1.04%
FY2020 37.4× 18.01%
FY2019 31.7× 16.85%
FY2018 27.1× (18.70%)
FY2017 33.3× 28.52%
FY2016 25.9× 11.42%

Quarterly newest first

Period EV/FCF Change
Jun 2026 22.5× 1.02%
Mar 2026 22.3× (57.30%)
Dec 2025 52.1× (34.68%)
Sep 2025 79.8× (18.96%)
42 more quarters

Against its own ten years

Low 10.8× High 123×
Ten-year median 32.6×
Current reading's percentile 16

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on BAX